Studies in adult patients suggest that glargine administration early in DKA management may improve the transition to subcutaneous insulin by accelerating the resolution of ketoacidosis, decreasing IV insulin duration and hospital length of stay, and reducing rebound hyperglycemia without increasing hypoglycemia.12, 13, 20, 21. This evidence concerns the gene INS and Hyperglycemia.